Treatment of human embryos with the TGF beta inhibitor SB431542 increases epiblast proliferation and permits successful human embryonic stem cell derivation

Author(s):
Jeught, M. van der; Heindryckx, B.; O'Leary, T.; Duggal, G.; Ghimire, S.; Lierman, S.; Roy, N. van; Lopes, S.M.C.D.; Deroo, T.; Deforce, D.; Sutter, P. de
Published
2014
Publication type
Article / Letter to editor
TGF beta inhibitionhuman embryo developmentepiblasthuman embryonic stem cell (hESC) derivationnaive hESC
Date issued
2014-01-31
Language
English
Is part of
Human Reproduction (2014), Vol. 29, no. 1, p. 41-48
hdl
1887/104816
doi
10.1093/humrep/det400